Abstract #1003586: Smart Insulin Pens Uncover the Need For Long Acting Insulin Dose Optimization in Multiple Daily Insulin Therapy
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A retrospective analysis of InPen system data indicated that 60% of device users required adjustments in their basal insulin dose.
“In fact, a retrospective analysis of InPen system data indicated 60% of device users required adjustments in their basal insulin dose.27”
From Shining the Spotlight on Multiple Daily Insulin Therapy: Real-World Evidence of the InPen Smart Insulin Pen (2024) · cites this paper as [27]
Cited by
Sorted by citations
MacLeod, J., Im, G. H., Smith, M., & Vigersky, R. A. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0365 · Cited by 40 · see citing works
Self-citationAdvantages and disadvantages of connected insulin pens in diabetes management
Lingen, K., Pikounis, T., Bellini, N. J., & Isaacs, D. M. (2023) · Endocrine Connections · doi:10.1530/ec-23-0108 · Cited by 32 · see citing works
“However, studies show despite this feature, HCPs often do not change a person’s dose (32).”
BackgroundMacLeod, J., & Vigersky, R. A. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221134546 · Cited by 24 · see citing works
Self-citationConnected Insulin Pens and Pen Caps: Expanding Diabetes Technology Access and Adoption
MacLeod, J. (2025) · Diabetes Spectrum · doi:10.2337/dsi25-0001 · Cited by 4 · see citing works
Self-citationDiabetes Technology: Continuous Glucose Monitoring and Insulin Delivery
MacLeod, J., Willis, H. J., Sulik, B., & Chomko, M. (2026) · American Diabetes Association eBooks · doi:10.2337/9781580408493-ch08
Self-citation
- Authors
- Smith, M. B., Gaetano, A., Vigersky, R., Cordero, T., & MacLeod, J.
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 27
- Issue
- 6
- Pages
- S49-S50
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W3172983372
- Cited by
- 5
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 2 · 2022: 1
- Type
- conference abstract
- Language
- en
- Open access
- closed
- Locations
- Endocrine Practice (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- smart insulin pens, long-acting insulin, insulin dose adjustment, type 1 diabetes, type 2 diabetes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
